Literature DB >> 18497692

Use of the piggyback hepatectomy technique in liver transplant recipients with hepatocellular carcinoma.

Richard S Mangus1, Jonathan A Fridell, Rodrigo M Vianna, Amanda B Cooper, Daniel T Jones, A Joe Tector.   

Abstract

The piggyback hepatectomy technique (PGB) is avoided in liver transplant patients with hepatocellular carcinoma (HCC) to decrease the theoretical risk of a positive vena cava margin or hematologic metastases. This study reports the routine use of PGB in 138 consecutive adult, deceased donor liver transplant recipients with HCC. Piggyback hepatectomy technique was used in 119 subjects, with 19 recipients receiving the conventional bicaval technique (CONV). Median follow-up was 34 months. There were 95 patients (69%) within and 43 patients (31%) outside, Milan criteria at transplant. Hepatocellular carcinoma recurrence rate was 13% and survival was 84.1% (1-year) and 77.4% (2-years). The PGB and CONV study groups did not differ in survival within or outside Milan criteria. Cox proportional hazards modeling of posttransplant survival demonstrated statistically similar survival for PGB and CONV. In conclusion, the presence of HCC in liver transplant patients should not preclude the use of PGB.

Entities:  

Mesh:

Year:  2008        PMID: 18497692     DOI: 10.1097/TP.0b013e31816feec0

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  9 in total

Review 1.  Obtaining Optimal Long-Term Outcomes from Liver Transplantation for Hepatocellular Cancer.

Authors:  Trevor W Reichman; Chandra S Bhati; Narendra R Battula
Journal:  Dig Dis Sci       Date:  2019-04       Impact factor: 3.199

2.  Recipient hepatectomy under total hepatic vascular exclusion to prevent hepatocellular carcinoma spread in living donor liver transplantation.

Authors:  Young-In Yoon; Shin Hwang; Deok-Bog Moon; Dong-Hwan Jung; Sung-Gyu Lee
Journal:  Korean J Transplant       Date:  2021-06-07

Review 3.  Impact of non-oncological factors on tumor recurrence after liver transplantation in hepatocellular carcinoma patients.

Authors:  Xiang-Qian Gu; Wei-Ping Zheng; Da-Hong Teng; Ji-San Sun; Hong Zheng
Journal:  World J Gastroenterol       Date:  2016-03-07       Impact factor: 5.742

Review 4.  Liver transplantation for hepatocellular carcinoma: outcomes and novel surgical approaches.

Authors:  Gonzalo Sapisochin; Jordi Bruix
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2017-01-05       Impact factor: 46.802

5.  Liver Transplantation Without Venovenous Bypass: Does Surgical Approach Matter?

Authors:  Andrew S Barbas; Jordan Levy; Michael S Mulvihill; Nicolas Goldaracena; Martin J Dib; David P Al-Adra; Mark S Cattral; Anand Ghanekar; Paul D Greig; David R Grant; Gonzalo Sapisochin; Markus Selzner; Stuart A McCluskey; Ian D McGilvray
Journal:  Transplant Direct       Date:  2018-04-24

Review 6.  Recurrence of Hepatocellular Carcinoma After Liver Transplantation: Risk Factors and Predictive Models.

Authors:  Wojciech Andrzej Straś; Dariusz Wasiak; Beata Łągiewska; Olga Tronina; Marta Hreńczuk; Joanna Gotlib; Wojciech Lisik; Piotr Małkowski
Journal:  Ann Transplant       Date:  2022-01-26       Impact factor: 1.530

7.  Contemporary strategies in the management of hepatocellular carcinoma.

Authors:  Shirin Elizabeth Khorsandi; Nigel Heaton
Journal:  HPB Surg       Date:  2012-11-04

8.  Tracheostomy Post Liver Transplant: Predictors, Complications, and Outcomes.

Authors:  Ryan C Graham; Weston J Bush; Jeffrey S Mella; Jonathan A Fridell; Burcin Ekser; Plamen Mihaylov; Chandrashekhar A Kubal; Richard S Mangus
Journal:  Ann Transplant       Date:  2020-08-11       Impact factor: 1.530

9.  Impact of Donor Pre-Procurement Cardiac Arrest (PPCA) on Clinical Outcomes in Liver Transplantation.

Authors:  Richard S Mangus; Joel R Schroering; Jonathan A Fridell; Chandrashekhar A Kubal
Journal:  Ann Transplant       Date:  2018-11-20       Impact factor: 1.530

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.